These findings prompted us to investigate the potential role of TAK1 in AD pathology, which is closely associated with age- and protein aggregation-triggered neuroinflammation in the hippocampus and the cortex (Blennow et al., 2006; Latta et al., 2015). The gene discussed is MAP3K7; the disease is Alzheimer disease.